More ACCESS Newswire

View Older Stories View Newer Stories

May 1, 2023 07:30AM Forward Water Technologies Announces Completion of Technology License with FUJIFILM Corporation
May 1, 2023 07:30AM Surge Battery Metals Announces the Appointment of Mr. Iain Scarr B.Sc. MBA as Director
May 1, 2023 07:30AM Rekor Systems to Announce First Quarter Fiscal 2023 Results
May 1, 2023 07:00AM Aston Bay Intersects Copper Mineralization in First Drill Holes at Storm Copper Project, Nunavut
May 1, 2023 07:00AM Metalite Resources Engages TD Media LLC
May 1, 2023 07:00AM Stratodesk Doubles Down on Its Channel Commitment With the Addition of Paul Austin as VP of Global Channels and Bill Chappell as Director of Solutions Enablement
May 1, 2023 07:00AM Mark Cohen of Cohen Financial Group Named the Top Individual Mortgage Broker in the U.S. by National Mortgage News
May 1, 2023 07:00AM Envision Pharma Group Appoints Industry Leader Tino Quintero as General Manager/VP of Market Access & Customer Insights
May 1, 2023 06:45AM Northern Dynasty: U.S. Army Corps Remand Highlights Serious Flaws in the Permitting Decision
May 1, 2023 06:00AM A2Z Partners with HaStok to Deploy 1,000 Smart Carts to their 40 Locations Nationwide
May 1, 2023 05:00AM Q Battery Metals Corp Contracts Maxima Resources Inc to Undertake Exploration on the Pegalith Lithium and La Corne South Projects Gatineau and Val d'Or, Quebec
May 1, 2023 03:45AM SPI Energy’s Solar4America Showing American-Made Solar Modules at Florida Solar & Storage Summit 2023
May 1, 2023 01:10AM Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
May 1, 2023 01:10AM Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
May 1, 2023 01:10AM Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
May 1, 2023 01:10AM Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
May 1, 2023 01:10AM Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
May 1, 2023 01:10AM Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
May 1, 2023 01:10AM Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
May 1, 2023 01:10AM Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
May 1, 2023 01:10AM Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
May 1, 2023 01:10AM Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
May 1, 2023 01:10AM Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
May 1, 2023 01:10AM Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
May 1, 2023 01:10AM Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
May 1, 2023 01:10AM Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
May 1, 2023 01:10AM Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
May 1, 2023 01:10AM Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
May 1, 2023 01:10AM Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
May 1, 2023 01:10AM Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
May 1, 2023 01:10AM Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
May 1, 2023 01:10AM Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
May 1, 2023 01:10AM CoTec Holdings Corp. Increases Interest in MagIron
May 1, 2023 01:10AM CoTec Holdings Corp. Increases Interest in MagIron
May 1, 2023 01:10AM CoTec Holdings Corp. Increases Interest in MagIron
May 1, 2023 01:10AM CoTec Holdings Corp. Increases Interest in MagIron
May 1, 2023 01:10AM CoTec Holdings Corp. Increases Interest in MagIron
May 1, 2023 01:10AM CoTec Holdings Corp. Increases Interest in MagIron
May 1, 2023 01:10AM CoTec Holdings Corp. Increases Interest in MagIron
May 1, 2023 01:10AM CoTec Holdings Corp. Increases Interest in MagIron
May 1, 2023 01:10AM CoTec Holdings Corp. Increases Interest in MagIron
May 1, 2023 01:10AM CoTec Holdings Corp. Increases Interest in MagIron
May 1, 2023 01:10AM CoTec Holdings Corp. Increases Interest in MagIron
May 1, 2023 01:10AM CoTec Holdings Corp. Increases Interest in MagIron
May 1, 2023 01:10AM CoTec Holdings Corp. Increases Interest in MagIron
May 1, 2023 01:10AM CoTec Holdings Corp. Increases Interest in MagIron
May 1, 2023 01:10AM CoTec Holdings Corp. Increases Interest in MagIron
May 1, 2023 01:10AM CoTec Holdings Corp. Increases Interest in MagIron
May 1, 2023 01:10AM CoTec Holdings Corp. Increases Interest in MagIron
May 1, 2023 01:10AM CoTec Holdings Corp. Increases Interest in MagIron
View Newer Stories View Older Stories